Ara
Toplam kayıt 47, listelenen: 21-30
CACTUS: cancer image annotating, calibrating, testing, understanding and sharing in breast cancer histopathology
(NLM (Medline), 2020)
OBJECTIVE: Develop CACTUS (cancer image annotating, calibrating, testing, understanding and sharing) as a novel web application for image archiving, annotation, grading, distribution, networking and evaluation. This helps ...
BreCaHAD: A dataset for breast cancer histopathological annotation and diagnosis
(BioMed Central Ltd., 2019)
Objectives: Histopathological tissue analysis by a pathologist determines the diagnosis and prognosis of most tumors, such as breast cancer. To estimate the aggressiveness of cancer, a pathologist evaluates the microscopic ...
Assessment of the Gail model in estimating the risk of breast cancer: Effect of cancer worry and risk in healthy women
(Asian Pacific Organization for Cancer Prevention, 2019)
Background: There has been substantial interest in developing methods to predict the risk of breast cancer. The Gail model is one the first model have been widely used to identify women at higher risk of breast cancer. ...
Automated scoring of CerbB2/HER2 receptors using histogram based analysis of immunohistochemistry breast cancer tissue images
(Elsevier Ltd, 2021)
Background and Objective: Visual expression of invasive breast cancer with immunohistochemistry (IHC) allows evaluation of CerbB2 receptors, such that CerbB2 mutated breast carcinomas are suitable for targeted therapy. ...
The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival
(Springer-Verlag, 2015)
In the literature, small number of study has addressed time of recurrence in breast cancer. We analyzed clinicopathological factors predicting early or late recurrence in breast cancer patients and also prognostic factors ...
An examination of health care utilization during the COVID-19 pandemic among women with early-stage hormone receptor-positive breast cancer
(BioMed Central Ltd, 2022)
Background: Women undergoing treatment for breast cancer require frequent clinic visits for maintenance of therapy. With COVID-19 causing health care disruptions, it is important to learn about how this population’s access ...
Chemopreventive effects of hydatid disease on experimental breast cancer
(Asian Pacific Organization for Cancer Prevention, 2015)
Breast cancer is one of the most common and letal cancers in all over the world. Since there have been significant improvements in treatment of breast cancer, there is still a big need for alternative approaches. In this ...
Important factors affecting adjuvant treatment decision in stage IA breast cancer patients in Turkey
(S. Karger AG, 2014)
Introduction: In Turkey, the gene expression profile test is not standard, so adjuvant treatment is planned according to clinicopathological factors. Therefore, we retrospectively analyzed important parameters that affect ...
Identification of ApoA1, HPX and POTEE genes by omic analysis in breast cancer
(Spandidos Publications, 2014)
Breast cancer is the most common cancer among women and accounts for 23% of all female types of cancers. It is well recognized that breast cancer represents a heterogeneous group of tumors, and the molecular events involved ...
Clinical importance of discordance of hormone receptors and Her2/neu status after neoadjuvant chemotherapy in breast cancer
(Zerbinis Medical Publications, 2014)
Purpose: The aim of this study was to compare the hormone receptors' (HR) and HER2/neu status between core needle biopsy (CNB) and residual tumor after surgery of breast cancer treated with neoadjuvant chemotherapy (NAC), ...